At the very beginning of the COVID-19 global pandemic, it was reported that this disease was mostly affecting adults aged 18 or above. However, over time, the U.S. Centers for Disease Control and Prevention (CDC) concluded that younger adults aged 20-29 seemed to account for more than 20% of the COVID-19 cases. After further studies, data from CDC showed that children under the age of 18 were also likely of contracting the virus.
This is where the concept of the Moderna vaccine and Moderna booster CPT codes came in. The scientific and research community worked on providing COVID-19 vaccination protection that would significantly reduce the risks of severe COVID-19 symptoms in approximately 18 million younger children.
While the Moderna vaccine for COVID-19 for young children awaits approval and authorization from the Foods and Drugs Administration (FDA), the American Medical Association (AMA) has announced the new Moderna booster CPT code. This ensures that the healthcare system throughout the United States is well prepared for this new vaccine’s potential use shortly. These booster codes are for children over the age of six months and under the age of five years and over the age of six years and under 11 years.
What is a Current Procedural Terminology (CPT) code?
A set of medical codes used to report medical, surgical, and diagnostic procedures to external entities such as health insurance companies are termed current procedural terminology. Moderna booster CPT codes, like any other CPT codes, are used for electronic medical billing in association with ICD-9-CM or ICD-10-CM diagnostic numerical coding.
There are three types of CPT codes available. Category 1 includes all procedures, FDA-approved drugs, and contemporary medical practices. These procedures include those that are widely performed at healthcare facilities. The CPT code for Moderna booster is also placed in Category 1. The second category or Category 2 involves a set of medical codes for clinical laboratory services, intended to track performance and information regarding quality care delivered. Category 3 CPT codes enlist the emerging services, procedures, and technologies.
Requiring an FDA approval – What is it?
During the trying times of COVID-19, everyone is looking to get vaccinated. However, the uncertainty regarding the effectiveness and side effects of the said vaccination lingers. An FDA-approved drug allows people to use it freely knowing it has already been tried, tested, and authorized by an approving body. During an FDA approval, the Center for Drug Evaluation and Research (CDER) analyzes and reviews the drug’s effects, ensuring that the drug is only made available in the market if its benefits outweigh potential risks.
CPT codes for Moderna Booster
The Moderna vaccine CPT codes are categorized into product CPT codes for the Moderna Pediatric COVID-19 vaccine specifically for children of age six months through five years. They include:
Product Code
91311 Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative-free, 25 mcg/0.25 mL dosage, for children aged from six months to five years
Administration Codes
0111A Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative-free, 25 mcg/0.25 mL dosage; first dose
0112A Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) [coronavirus disease (COVID-19)] vaccine, mRNA-LNP, spike protein, preservative-free, 25 mcg/0.25 mL dosage; second dose
Similarly, the Moderna booster CPT codes are categorized into product CPT codes for the Moderna Pediatric COVID-19 vaccine specifically for children of age six through eleven years. They include:
Product Code
91309 Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) [coronavirus disease (COVID-19)] vaccine, mRNA-LNP, spike protein, preservative-free, 50 mcg/0.5 mL dosage, for intramuscular use.
Administration Codes
0091A Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) [coronavirus disease (COVID-19)] vaccine, mRNA-LNP, spike protein, preservative-free, 50 mcg/0.5 mL dosage; first dose when administered to individuals aged 6 through 11 years.
0092A Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) [coronavirus disease (COVID-19)] vaccine, mRNA-LNP, spike protein, preservative-free, 50 mcg/0.5 mL dosage; second dose when administered to individuals aged 6 through 11 years.
0093A Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) [coronavirus disease (COVID-19)] vaccine, mRNA-LNP, spike protein, preservative-free, 50 mcg/0.5 mL dosage; third dose when administered to individuals aged 6 through 11 years.
0094A Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) [coronavirus disease (COVID-19)] vaccine, mRNA-LNP, spike protein, preservative-free, 50 mcg/0.5 mL dosage; booster dose when administered to individuals 18 years and over.
Administration of the Moderna COVID-19 Vaccine
The Moderna COVID-19 is an mRNA vaccine that follows an intramuscular administration in a series of two doses. Each dose is 0.5 ml and is given at a 4-week interval. The Moderna booster shot follows the second vaccination at a 24-week interval. The mRNA technology of the Moderna vaccine gives it an efficacy of greater than 90%, making it one of the most effective COVID-19 vaccines administered to date.
Who can be vaccinated with Moderna COVID-19 Vaccination?
FDA has authorized the use of the Moderna vaccination on children older than 11 years of age. This vaccine and a booster shot are recommended for:
- Breastfeeding women
- Healthcare workers who are exposed to suspected or confirmed covid-19 patients
- Patients with HIV infections
- Patients with underlying diseases such as asthma, hypertension, diabetes, and lung and respiratory diseases, which makes them vulnerable to contracting the covid-19 virus
We advise elderly people, immunocompromised patients, and pregnant women to seek their doctor’s approval before receiving the vaccination or booster shots.
Most Common Side Effects of the Moderna COVID-19 Vaccine and Booster
The side effects of the Moderna vaccine usually begin a day or two after receiving the shot. Contrary to popular belief, the side effects are a sign that your body is building up your immune system to protect you from the virus in the future. Mostly, these symptoms subside over time, lasting for about two to five days. These include:
- Headache
- Fever or chills
- Exhaustion
- Nausea
- Redness, pain, or swelling at the injection site
If any of the fever or pain symptoms do not subside over time, paracetamol can be taken as advised by your healthcare professional. However, in cases of serious adverse reactions, such as anaphylaxis (body’s severe allergic reaction to an allergen, which causes the body to go into shock and shut down on its own), myocarditis (inflammation of the myocardium or the heart muscle), and pericarditis (inflammation of the pericardium or the sac-like structure surrounding the heart), immediate medical attention is required.
See Also: How And When To Use CPT Code 96372
Conclusion
We believe that extending COVID-19 vaccination and booster protection altogether reduces the risks of your child developing a severe infection, which may result in hospitalization. People are encouraged to receive booster shots to significantly reduce the burden on healthcare systems.
At Precision Hub, we encourage all parents to get their infants, toddlers, and other children vaccinated fully as soon as they are eligible for their COVID-19 vaccine. We enable your healthcare facility to deliver patient-centered care by offering credentialing, consulting, and financing services. Reach out to us today and optimize your workflow with front and back office management!
No comment yet, add your voice below!